“…Although vancomycin MICs Յ 2 g/ml are considered to represent susceptibility, treatment of invasive infections due to MRSA strains with drug MICs ranging from 1 to 2 g/ml has had a lower success rate than treatment of infections due to strains with drug MICs Յ 0.5 g/ml (9, 41). Despite reports over the past several years of MRSA isolates displaying reduced vancomycin susceptibility ("MIC creep") (9,45,46,51), others have demonstrated MIC stability in the setting of low vancomycin consumption (2). More recently, data from a large U.S. multicenter study suggested that reports of MIC creep may be exaggerated and that it perhaps poses less of a widespread problem than the reports have indicated (40).…”